316 related articles for article (PubMed ID: 29320158)
1. Coordination-Mediated Synthesis of Purification-Free Bivalent
Taira Y; Uehara T; Tsuchiya M; Takemori H; Mizuno Y; Takahashi S; Suzuki H; Hanaoka H; Akizawa H; Arano Y
Bioconjug Chem; 2018 Feb; 29(2):459-466. PubMed ID: 29320158
[TBL] [Abstract][Full Text] [Related]
2. Manipulating Pharmacokinetics of Purification-Free
Uehara T; Sensui A; Ishioka S; Mizuno Y; Takahashi S; Takemori H; Suzuki H; Arano Y
Mol Pharm; 2020 May; 17(5):1621-1628. PubMed ID: 32275437
[TBL] [Abstract][Full Text] [Related]
3. Purification-Free Method for Preparing Technetium-99m-Labeled Multivalent Probes for Enhanced in Vivo Imaging of Saturable Systems.
Mizuno Y; Uehara T; Hanaoka H; Endo Y; Jen CW; Arano Y
J Med Chem; 2016 Apr; 59(7):3331-9. PubMed ID: 26999587
[TBL] [Abstract][Full Text] [Related]
4. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
5. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
6. Imaging of Integrin α
Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
[TBL] [Abstract][Full Text] [Related]
7. [
Kaihani S; Sadeghzadeh N; Abediankenari S; Abedi SM
Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
[TBL] [Abstract][Full Text] [Related]
8. 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.
Shi J; Wang L; Kim YS; Zhai S; Jia B; Wang F; Liu S
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1874-84. PubMed ID: 19484236
[TBL] [Abstract][Full Text] [Related]
9. Aryl isocyanide derivative for one-pot synthesis of purification-free
Mizuno Y; Komatsu N; Uehara T; Shimoda Y; Kimura K; Arano Y; Akizawa H
Nucl Med Biol; 2020; 86-87():30-36. PubMed ID: 32470868
[TBL] [Abstract][Full Text] [Related]
10. Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.
Dearling JL; Barnes JW; Panigrahy D; Zimmerman RE; Fahey F; Treves ST; Morrison MS; Kieran MW; Packard AB
Nucl Med Biol; 2013 Aug; 40(6):788-94. PubMed ID: 23701702
[TBL] [Abstract][Full Text] [Related]
11. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
[TBL] [Abstract][Full Text] [Related]
13. Preclinical SPECT Imaging of Choroidal Neovascularization in Mice Using Integrin-Binding [
Ahn SJ; Lee HY; Hong HK; Jung JH; Park JH; Park KH; Kim SE; Woo SJ; Lee BC
Mol Imaging Biol; 2019 Aug; 21(4):644-653. PubMed ID: 30460625
[TBL] [Abstract][Full Text] [Related]
14. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
15. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.
Ji S; Zhou Y; Shao G; Liu S
Bioconjug Chem; 2013 Apr; 24(4):701-11. PubMed ID: 23521129
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
Zhou Y; Kim YS; Lu X; Liu S
Bioconjug Chem; 2012 Mar; 23(3):586-95. PubMed ID: 22369387
[TBL] [Abstract][Full Text] [Related]
19. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.
Liu S; Hsieh WY; Kim YS; Mohammed SI
Bioconjug Chem; 2005; 16(6):1580-8. PubMed ID: 16287258
[TBL] [Abstract][Full Text] [Related]
20. Comparison of biological properties of
Zhao ZQ; Yang Y; Fang W; Liu S
Nucl Med Biol; 2016 Nov; 43(11):661-669. PubMed ID: 27556955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
